CRS Report for CongressPrepared for Members and Committees of Congress FDA Fast Track and Priority Review Programs -name redacted- Specialist in Drug Safety and Effectiveness February 21, 2008 Congressional Research Service7-. www.crs.gov RS22814
升级VIP 